Posted by Michael Wonder on 08 Aug 2023
Major US health systems expect to offer Alzheimer's drug Leqembi in a few months
7 August 2023 - Five major US health systems said they would offer Eisai and Biogen's promising new Alzheimer's drug Leqembi after working out payment and administrative policies, and how to assess and monitor patients, most likely in the next month or two.
Leqembi, which won full US regulatory approval last month, is the first treatment proven to slow progression of the mind-robbing disease for people in the earliest stages of Alzheimer's disease.
